Danaher Corporation is a global life sciences and diagnostics innovator that provides technologies, tools, and services to accelerate the development of biotechnology therapies, improve diagnostic accuracy, and support life sciences research. The company serves healthcare and scientific customers worldwide to help advance medical innovations and improve human health.
Subscribe to see Danaher Incheon’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Danaher Incheon is a medical devices company headquartered in South Korea. Xcout tracks 8 named people at Danaher Incheon, including Julie Sawyer Montgomery (President and Chief Executive Officer).
2 more named people on record for Danaher Incheon, with roles, board committees and tenure — see the full roster →
A few of Danaher Incheon's closest competitors — see the full list of competitors and alternatives →
PerkinElmer provides analytical instruments, laboratory services, software, and consumables across industries such as food safety, environmental analysis, applied markets, and biopharma. The company serves scientists and operators globally with testing and measurement solutions.
BD (Becton, Dickinson and Company) is a global medical technology company that manufactures and provides medical devices, instrument systems, and reagents. It serves healthcare institutions, life sciences researchers, clinical laboratories, and the pharmaceutical industry with solutions for medication management, diagnostics, infection prevention, and surgery.
Beckman Coulter Diagnostics provides clinical diagnostic products, laboratory automation systems, and testing solutions across disciplines such as chemistry, immunoassay, hematology, and microbiology. The company serves healthcare providers and laboratories by delivering accurate and timely diagnostic insights to inform clinical decisions and improve patient care.
Beckman Coulter is a medical technology company that develops and supplies laboratory instruments, automation systems, and diagnostic tests for clinical laboratories, hospitals, and research institutions. Its operations in Spain serve healthcare and laboratory customers with clinical diagnostics and related support services.
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
Biohit Oyj is a Finnish biotechnology company that develops and markets products and services for medical research, early diagnosis, and disease prevention. Its offerings include gastrointestinal diagnostic tests, laboratory equipment, monoclonal antibodies, and health-related consumer products such as the Acetium series.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.